BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vranic S, Cyprian FS, Akhtar S, Al Moustafa AE. The Role of Epstein-Barr Virus in Cervical Cancer: A Brief Update. Front Oncol 2018;8:113. [PMID: 29719817 DOI: 10.3389/fonc.2018.00113] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Cone AS, York SB, Meckes DG Jr. Extracellular Vesicles in Epstein-Barr Virus Pathogenesis. Curr Clin Microbiol Rep 2019;6:121-31. [PMID: 32051811 DOI: 10.1007/s40588-019-00123-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
2 Bedri S, Sultan AA, Alkhalaf M, Al Moustafa AE, Vranic S. Epstein-Barr virus (EBV) status in colorectal cancer: a mini review. Hum Vaccin Immunother 2019;15:603-10. [PMID: 30380978 DOI: 10.1080/21645515.2018.1543525] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
3 Ghosh S, Shetty RS, Pattanshetty SM, Mallya SD, Pandey D, Kabekkodu SP, Kamath VG, Prabhu N, D'souza J, Satyamoorthy K. Human papilloma and other DNA virus infections of the cervix: A population based comparative study among tribal and general population in India. PLoS One 2019;14:e0219173. [PMID: 31247023 DOI: 10.1371/journal.pone.0219173] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
4 Venkatas J, Singh M. Cervical cancer: a meta-analysis, therapy and future of nanomedicine. Ecancermedicalscience 2020;14:1111. [PMID: 33144879 DOI: 10.3332/ecancer.2020.1111] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Fernandes Q, Gupta I, Vranic S, Al Moustafa AE. Human Papillomaviruses and Epstein-Barr Virus Interactions in Colorectal Cancer: A Brief Review. Pathogens 2020;9:E300. [PMID: 32325943 DOI: 10.3390/pathogens9040300] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
6 Khandia R, Munjal A. Interplay between inflammation and cancer. Inflammatory Disorders, Part A. Elsevier; 2020. pp. 199-245. [DOI: 10.1016/bs.apcsb.2019.09.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
7 Nahand JS, Khanaliha K, Mirzaei H, Moghoofei M, Baghi HB, Esghaei M, Khatami AR, Fatemipour M, Bokharaei-Salim F. Possible role of HPV/EBV coinfection in anoikis resistance and development in prostate cancer. BMC Cancer 2021;21:926. [PMID: 34399719 DOI: 10.1186/s12885-021-08658-y] [Reference Citation Analysis]
8 Cyprian FS, Al-Farsi HF, Vranic S, Akhtar S, Al Moustafa AE. Epstein-Barr Virus and Human Papillomaviruses Interactions and Their Roles in the Initiation of Epithelial-Mesenchymal Transition and Cancer Progression. Front Oncol 2018;8:111. [PMID: 29765906 DOI: 10.3389/fonc.2018.00111] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 6.5] [Reference Citation Analysis]
9 Nagi K, Gupta I, Jurdi N, Yasmeen A, Vranic S, Batist G, Moustafa AA. Copresence of High-Risk Human Papillomaviruses and Epstein-Barr Virus in Colorectal Cancer: A Tissue Microarray and Molecular Study from Lebanon. Int J Mol Sci 2021;22:8118. [PMID: 34360884 DOI: 10.3390/ijms22158118] [Reference Citation Analysis]
10 Onisiforou A, Spyrou GM. Identification of viral-mediated pathogenic mechanisms in neurodegenerative diseases using network-based approaches. Brief Bioinform 2021:bbab141. [PMID: 34237135 DOI: 10.1093/bib/bbab141] [Reference Citation Analysis]
11 Al-Thawadi H, Ghabreau L, Aboulkassim T, Yasmeen A, Vranic S, Batist G, Al Moustafa AE. Co-Incidence of Epstein-Barr Virus and High-Risk Human Papillomaviruses in Cervical Cancer of Syrian Women. Front Oncol 2018;8:250. [PMID: 30035100 DOI: 10.3389/fonc.2018.00250] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
12 Mughal MJ, Kwok HF. Multidimensional role of bacteria in cancer: Mechanisms insight, diagnostic, preventive and therapeutic potential. Semin Cancer Biol 2021:S1044-579X(21)00181-4. [PMID: 34119644 DOI: 10.1016/j.semcancer.2021.06.011] [Reference Citation Analysis]
13 Joharinia N, Faghihinejad S, Seyedi K, Farhadi A, Hosseini SY, Safaei A, Bahrampour H, Sarvari J. Co-existing of HSV1/2 or EBV Infection with the Presence of High-Risk HPV DNA in Cervical Lesions in the Southwest of Iran. Asian Pac J Cancer Prev 2020;21:1459-64. [PMID: 32458656 DOI: 10.31557/APJCP.2020.21.5.1459] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
14 Dass SA, Selva Rajan R, Tye GJ, Balakrishnan V. The potential applications of T cell receptor (TCR)-like antibody in cervical cancer immunotherapy. Hum Vaccin Immunother 2021;17:2981-94. [PMID: 33989511 DOI: 10.1080/21645515.2021.1913960] [Reference Citation Analysis]
15 Gupta I, Nasrallah GK, Sharma A, Jabeen A, Smatti MK, Al-Thawadi HA, Sultan AA, Alkhalaf M, Vranic S, Moustafa AA. Co-prevalence of human Papillomaviruses (HPV) and Epstein-Barr virus (EBV) in healthy blood donors from diverse nationalities in Qatar. Cancer Cell Int 2020;20:107. [PMID: 32265596 DOI: 10.1186/s12935-020-01190-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
16 Malki MI, Gupta I, Fernandes Q, Aboulkassim T, Yasmeen A, Vranic S, Al Moustafa AE, Al-Thawadi HA. Co-presence of Epstein-Barr virus and high-risk human papillomaviruses in Syrian colorectal cancer samples. Hum Vaccin Immunother 2020;16:2403-7. [PMID: 32186955 DOI: 10.1080/21645515.2020.1726680] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]